Skip to main content

Rachel Sachs is the Treiman Professor of Law at Washington University in St. Louis School of Law and a nonresident fellow at Brookings. She is a nationally renowned scholar of innovation policy, exploring exploring health law, food and drug regulation, and intellectual property law.

Prior to joining the law faculty at Washington University in St. Louis, Professor Sachs was an academic fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and a lecturer in Law at Harvard Law School. Her scholarship has appeared in The NYU Law ReviewThe Michigan Law ReviewThe Harvard Law ReviewThe New England Journal of Medicine, and The Journal of the American Medical Association. She also clerked for the Hon. Richard A. Posner of the U.S. Court of Appeals for the Seventh Circuit.

While at Washington University in St. Louis, Professor Sachs has engaged with state and federal policymakers on the topic of prescription drug pricing, including testifying before the United States Congress. She currently serves on the Board of Editors for the Journal of Health Politics, Policy, and Law.

Rachel Sachs is the Treiman Professor of Law at Washington University in St. Louis School of Law and a nonresident fellow at Brookings. She is a nationally renowned scholar of innovation policy, exploring exploring health law, food and drug regulation, and intellectual property law.

Prior to joining the law faculty at Washington University in St. Louis, Professor Sachs was an academic fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and a lecturer in Law at Harvard Law School. Her scholarship has appeared in The NYU Law ReviewThe Michigan Law ReviewThe Harvard Law ReviewThe New England Journal of Medicine, and The Journal of the American Medical Association. She also clerked for the Hon. Richard A. Posner of the U.S. Court of Appeals for the Seventh Circuit.

While at Washington University in St. Louis, Professor Sachs has engaged with state and federal policymakers on the topic of prescription drug pricing, including testifying before the United States Congress. She currently serves on the Board of Editors for the Journal of Health Politics, Policy, and Law.

Get daily updates from Brookings